Literature DB >> 19292163

Proximal row carpectomy with capitate resection and capsular interposition for treatment of scapholunate advanced collapse.

Jeffrey D Placzek1, Martin I Boyer, Farhang Raaii, D Carl Freeman, Richard H Gelberman.   

Abstract

Proximal row carpectomy with capitate head resection and dorsal capsular interposition was performed in 8 patients with stage II and III scapholunate advanced collapse (SLAC). Mean patient age was 58.5 years (range, 50-79 years). One year postoperatively, range of motion and grip strength were not significantly changed from preoperative values. Mean postoperative Disabilities of the Arm, Shoulder, and Hand questionnaire score was 27. Pain improved from 8.8 preoperatively to 4.3 postoperatively on a scale of 0-10. Pain levels were highly inversely correlated with final range of motion (r=-0.94, P=.0004). Proximal row carpectomy with capitate leveling and capsular interposition for stage II and III SLAC wrist provides reasonable pain relief in 75% of patients. Patients should be counseled that 25% of cases may demonstrate progression of radiocapitate degeneration, necessitating further intervention.

Entities:  

Mesh:

Year:  2008        PMID: 19292163     DOI: 10.3928/01477447-20080101-37

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  3 in total

1.  Common radiographic imaging modalities fail to accurately predict capitate morphology.

Authors:  Timothy Niacaris; Victor W Wong; Ketan M Patel; Michael Januszyk; Trevor Starnes; Michael S Murphy; James P Higgins
Journal:  Hand (N Y)       Date:  2015-09

2.  Scapholunate advanced collapse (SLAC) and scaphoid nonunion advanced collapse (SNAC) wrist arthritis.

Authors:  Chirag M Shah; Peter J Stern
Journal:  Curr Rev Musculoskelet Med       Date:  2013-03

3.  Proximal Row Carpectomy Using Decellularized Dermal Allograft: Preliminary Results.

Authors:  Steven J Lee; Remy V Rabinovich; Andrew Kim
Journal:  J Wrist Surg       Date:  2020-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.